# LOPINAVIR AND RITONAVIR
> **ANDA207407** · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT CO INC · Approved 2016-12-27
## Drug
- **FDA Application Number:** ANDA207407
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOPINAVIR AND RITONAVIR
- **Generic name:** Lopinavir
- **Active ingredients:** LOPINAVIR; RITONAVIR
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LANNETT CO INC
- **First approval:** 2016-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207407)
---
*AI Analytics · CC0 1.0*